ticlopidine has been researched along with Leukocytopenia in 10 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of leukopenia in a patient receiving clopidogrel following intracoronary stent placement." | 7.72 | Clopidogrel-associated leukopenia. ( Kockler, DR; McCarthy, MW, 2003) |
| "Ticlopidine is increasingly used in the secondary prophylaxis in patients with arterial occlusive diseases." | 7.70 | Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. ( Ehringer, H; Minar, E; Parschalk, B; Redlich, K, 1999) |
| "To report a case of leukopenia in a patient receiving clopidogrel following intracoronary stent placement." | 3.72 | Clopidogrel-associated leukopenia. ( Kockler, DR; McCarthy, MW, 2003) |
| "Ticlopidine is increasingly used in the secondary prophylaxis in patients with arterial occlusive diseases." | 3.70 | Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. ( Ehringer, H; Minar, E; Parschalk, B; Redlich, K, 1999) |
| " From a dose-response showing that the administration of increasing doses of tissue thromboplastin resulted in a subsequent progressive increase of thrombus weight, two concentrations of tissue thromboplastin were chosen: a high dose (550 microL/kg, IV) where thrombus formation was optimal and a concentration (7 microL/kg, IV) where tissue thromboplastin-hypercoagulability was intermediate." | 1.28 | Importance of platelets in experimental venous thrombosis in the rat. ( Bernat, A; Herbert, JM; Maffrand, JP, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaret, BL | 1 |
| Zaret, M | 1 |
| Hayashi, K | 1 |
| Ohtsu, F | 1 |
| Yano, R | 1 |
| Sakakibara, J | 1 |
| Goto, N | 1 |
| McCarthy, MW | 1 |
| Kockler, DR | 1 |
| Kummer, O | 1 |
| Haschke, M | 1 |
| Tuchscherer, D | 1 |
| Lampert, M | 1 |
| Martius, F | 1 |
| Krähenbühl, S | 1 |
| Dunlop, H | 1 |
| Siu, K | 1 |
| Redlich, K | 1 |
| Parschalk, B | 1 |
| Ehringer, H | 1 |
| Minar, E | 1 |
| Alter, P | 1 |
| Schaefer, JR | 1 |
| Maisch, B | 1 |
| Herbert, JM | 1 |
| Bernat, A | 1 |
| Maffrand, JP | 1 |
| Grekas, D | 1 |
| Syrganis, C | 1 |
| Georgiou, T | 1 |
| Zegla, O | 1 |
| Tourkantonis, A | 1 |
1 trial available for ticlopidine and Leukocytopenia
| Article | Year |
|---|---|
Biocompatibility of cuprophan and cellulose acetate membranes. Prevention of dialysis hypoxemia and leucopenia by ticlopidine.
Topics: Adult; Aged; Biocompatible Materials; Cellulose; Complement Activation; Female; Humans; Hypoxia; Leu | 1985 |
9 other studies available for ticlopidine and Leukocytopenia
| Article | Year |
|---|---|
Purim CPR.
Topics: Attitude of Health Personnel; Cardiology; Cardiopulmonary Resuscitation; Diagnosis, Differential; Em | 2009 |
[Risk factors and subjective symptoms of drug-induced leucopenia].
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Autoimmune Dise | 2011 |
Clopidogrel-associated leukopenia.
Topics: Aged; Aged, 80 and over; Clopidogrel; Female; Humans; Leukopenia; Male; Middle Aged; Ticlopidine | 2003 |
[Agranulocytosis in a patient treated with metamizole and clopidogrel].
Topics: Aged; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; Cerebral Infarction; Cl | 2006 |
Adverse haematological effects of ticlopidine.
Topics: Clinical Trials as Topic; Cost-Benefit Analysis; France; Hemorrhage; Humans; Leukopenia; Platelet Ag | 1998 |
Serious hematologic reactions associated with ticlopidine--update.
Topics: Adverse Drug Reaction Reporting Systems; Hemorrhage; Humans; Leukopenia; Patient Education as Topic; | 1999 |
Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C.
Topics: Aged; Arterial Occlusive Diseases; Bone Marrow; Female; Hepatitis C, Chronic; Humans; Leukemia, Lymp | 1999 |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis].
Topics: Agranulocytosis; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Coronary Dis | 2000 |
Importance of platelets in experimental venous thrombosis in the rat.
Topics: Animals; Blood Platelets; Clopidogrel; Disease Models, Animal; Heparin; Hirudins; Leukopenia; Male; | 1992 |